Literature DB >> 12760879

RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.

Andrea Giacometti1, Oscar Cirioni, Yael Gov, Roberto Ghiselli, Maria Simona Del Prete, Federico Mocchegiani, Vittorio Saba, Fiorenza Orlando, Giorgio Scalise, Naomi Balaban, Giorgio Dell'Acqua.   

Abstract

Staphylococcus aureus is a prevalent cause of bacterial infections associated with indwelling medical devices. RNA III inhibiting peptide (RIP) is known to inhibit S. aureus pathogenesis by disrupting quorum-sensing mechanisms. RIP was tested in the present study for its ability to inhibit S. aureus biofilm formation in a rat Dacron graft model. The activity of RIP was synergistic with those of antibiotics for the complete prevention of drug-resistant S. aureus infections.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12760879      PMCID： PMC155823          DOI： 10.1128/AAC.47.6.1979-1983.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production.

Authors:  O Vieira-da-Motta; P D Ribeiro; W Dias da Silva; E Medina-Acosta
Journal:  Peptides       Date:  2001-10       Impact factor: 3.750

2.  Bacterial interference caused by autoinducing peptide variants.

Authors:  G Ji; R Beavis; R P Novick
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells.

Authors:  Naomi Balaban; Yael Gov; Arkady Bitler; Johan R Boelaert
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

4.  Studies on the duration of antibiotic administration for surgical prophylaxis.

Authors:  K S Scher
Journal:  Am Surg       Date:  1997-01       Impact factor: 0.688

5.  RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis.

Authors:  Y Gov; A Bitler; G Dell'Acqua; J V Torres; N Balaban
Journal:  Peptides       Date:  2001-10       Impact factor: 3.750

6.  Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.

Authors:  Naomi Balaban; Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Federico Mocchegiani; Claudio Viticchi; Maria Simona Del Prete; Vittorio Saba; Giorgio Scalise; Giorgio Dell'Acqua
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

7.  Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs.

Authors:  Kristina M Smith; Yigong Bu; Hiroaki Suga
Journal:  Chem Biol       Date:  2003-01

8.  Prophylactic antibiotics prevent bacterial biofilm graft infection.

Authors:  T M Bergamini; J C Peyton; W G Cheadle
Journal:  J Surg Res       Date:  1992-02       Impact factor: 2.192

9.  The critical relationship of antibiotic dose and bacterial contamination in experimental infection.

Authors:  M S Citak; J I Cué; J C Peyton; M A Malangoni
Journal:  J Surg Res       Date:  1992-02       Impact factor: 2.192

10.  Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.

Authors:  R P Novick; H F Ross; S J Projan; J Kornblum; B Kreiswirth; S Moghazeh
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598
View more
  25 in total

1.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 2.  Biofilm: the microbial "bunker" for intravascular catheter-related infection.

Authors:  Manuel Morales; Sebastián Méndez-Alvarez; Juana-Victoria Martín-López; Carmen Marrero; César O Freytes
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603

Review 3.  Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal.

Authors:  Diane McDougald; Scott A Rice; Nicolas Barraud; Peter D Steinberg; Staffan Kjelleberg
Journal:  Nat Rev Microbiol       Date:  2011-11-28       Impact factor: 60.633

Review 4.  Small molecule control of bacterial biofilms.

Authors:  Roberta J Worthington; Justin J Richards; Christian Melander
Journal:  Org Biomol Chem       Date:  2012-10-07       Impact factor: 3.876

5.  Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds.

Authors:  Ge Zhao; Phillip C Hochwalt; Marcia L Usui; Robert A Underwood; Pradeep K Singh; Garth A James; Philip S Stewart; Philip Fleckman; John E Olerud
Journal:  Wound Repair Regen       Date:  2010-08-19       Impact factor: 3.617

6.  Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence.

Authors:  Moshe Korem; Yael Gov; Madanahally D Kiran; Naomi Balaban
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

Authors:  Naomi Balaban; Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Joel B Braunstein; Carmela Silvestri; Federico Mocchegiani; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

8.  Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation.

Authors:  Laura H Tsang; Sonja T Daily; Elizabeth C Weiss; Mark S Smeltzer
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

9.  Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing.

Authors:  C A Martin; A D Hoven; A M Cook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-06       Impact factor: 3.267

10.  Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis.

Authors:  Jiro Nakayama; Emi Tanaka; Reiko Kariyama; Koji Nagata; Kenzo Nishiguchi; Ritsuko Mitsuhata; Yumi Uemura; Masaru Tanokura; Hiromi Kumon; Kenji Sonomoto
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.